Hosted on MSN
Recursion Pharmaceuticals projects $100M synergies in 2025 amid advancing pipeline and partnerships
CEO Chris Gibson highlighted significant progress in 2024, including clinical data readouts from REC-617 and REC-994, which showed early efficacy signals and robust safety, respectively. REC-617, a ...
Yesterday, we discussed effective verbal communication in job interviews - saying the right things and avoiding the wrong sorts of responses that can perhaps lose you the job. Today, let's focus on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results